ghk cu before and after injection vs. 3 months of GHK-Cu peptide therapy 🪄 • smoother texture, more even tone, skin that looks healthier overall. Small peptide, big difference 💙 GHKCU Skin Transformation Results After

Key findings include: GLP3 monotherapy achieved 22.8-24.2% mean weight reduction at 48 weeks in phase 2 obesity trials (8-12 mg doses) Cagrilintide monotherapy produced 10.8% weight loss over 26 weeks in phase 2 studies (2.4 mg dose) CagriSema combination (cagrilintide + semaglutide) achieved 20.4% weight loss at 68 weeks in phase 3 REDEFINE trials Combination approaches consistently outperformed single-agent therapies across multiple dose ranges Studies demonstrated that 100% of participants receiving GLP3 8 mg or higher achieved at least 5% weight loss, with 75-83% achieving 15% or greater weight reduction[9]

The non-invasive nature of IV therapy makes it an appealing option for many individuals seeking nutritional support

In an I/R-mediated myocardial injury model, pretreatment with Tan IIA activated the GSH system by increasing Nrf2 expression [154]

Henderson, J